NASDAQ:SGNT (SGNT) (SGNT) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free SGNT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$21.76▼$21.7650-Day Range N/A52-Week Range$10.55▼$21.88VolumeN/AAverage Volume607,514 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (SGNT) alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About (SGNT) Stock (NASDAQ:SGNT)Sagent Pharmaceuticals, Inc. is a specialty and generic pharmaceutical company. The Company is a provider of pharmaceuticals to the hospital market, which it sells primarily throughout North America. It is focused on developing, manufacturing, sourcing and marketing injectable pharmaceutical products to the hospital market. It operates through two segments: Sagent US, consisting of the Company's operations in the United States and the Sagent (China) Pharmaceuticals Co. Ltd. (SCP) manufacturing facility, and Omega, which is focused on the Canadian and international markets. It offers a range of products across anti-infective, oncology and critical care indications in a range of presentations, including single and multi-dose vials, pre-filled ready-to-use syringes and premix bags. Its Sagent US product portfolio includes approximately 60 marketed products that it offers in over 180 presentations, and its Omega segment offers over 50 products.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> SGNT Stock News HeadlinesApril 22, 2024 | msn.comSan Jose fire captain among more than 20 arrested in child predator sting operationNovember 22, 2023 | msn.comFairfield man arrested in connection to Monday’s Vallejo shootingApril 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.August 22, 2023 | investing.comNihar Info Global Ltd (NIHR)May 8, 2023 | thestreet.comChanging Landscape for Generic-Drug Makers Creates OpportunitiesApril 30, 2023 | msn.comTrying to find someone to take out all the caulking around my windows outside and redo, replace some cedar siding and all corners have holes from woodpeckers.April 15, 2023 | msn.comOlivia Wilde will helm a tv adaptation of A Visit from the Goon SquadApril 4, 2023 | msn.comNo One Cares About Kamala HarrisApril 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 12, 2023 | msn.com'Please be patient': MBTA update on speed restrictionsMarch 10, 2023 | msn.comChicago River Dyeing 2023, St. Patrick's Day Parade To Take Place This WeekendFebruary 22, 2023 | technews.tmcnet.comLatticeFlow AG Appoints Global Technology Executive, Andre Boisvert, As Chairman of The BoardJanuary 2, 2023 | thestreet.comSagent Pharmaceuticals (SGNT) Soared Today on Nichi-Iko DealDecember 3, 2022 | msn.comWC Daily Preview: USA/NED, ARG/AUS open Round of 16September 20, 2022 | investing.comSalora International Ltd (SALI)September 15, 2022 | msn.comCharacter Designs That Drastically ChangedAugust 9, 2022 | msn.comJane Seymour hails close friend Olivia Newton-John for ‘changing the world’August 8, 2022 | msn.comWhat On Earth Will A Live-Action Pac-Man Movie Look Like?July 14, 2022 | investing.comSungold Capital Ltd (SUNG)December 2, 2021 | bbc.co.ukJeane Freeman: Inside The PandemicNovember 13, 2021 | dailymail.co.ukCleo Smith: Terrified neighbour of alleged doll-obsessed kidnapper fears locals will burn down houseNovember 11, 2021 | dailymail.co.ukCleo Smith: Forensics spray substance in Carnarvon, WA as Mark McGowan shoots down $1million rewardNovember 9, 2021 | dailymail.co.ukCar of Cleo Smith's alleged abductor becomes focus of investigation as officers scour phone recordsNovember 8, 2021 | msn.comHero detective who found missing girl Cleo Smith visits family homeNovember 8, 2021 | dailymail.co.ukHero detective who led Cleo Smith's rescue visits family home ahead of a week of crucial interviewsSee More Headlines Receive SGNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (SGNT) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/04/2015Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryPharmaceuticals Current SymbolNASDAQ:SGNT CUSIP78669210 CIK1369786 Webwww.sagentpharma.com Phone+1-847-9081604FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report SGNT Stock Analysis - Frequently Asked Questions How were (SGNT)'s earnings last quarter? (SGNT) (NASDAQ:SGNT) issued its earnings results on Tuesday, August, 4th. The company reported ($0.01) EPS for the quarter, missing analysts' consensus estimates of $0.05 by $0.06. The company had revenue of $77.30 million for the quarter, compared to analysts' expectations of $83.28 million. The company's quarterly revenue was up 11.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.09 EPS. What other stocks do shareholders of (SGNT) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (SGNT) investors own include Mazor Robotics (MZOR), Endocyte (ECYT), Inovio Pharmaceuticals (INO), Surgery Partners (SGRY), Allena Pharmaceuticals (ALNA), Catalyst Biosciences (CBIO), Chatham Lodging Trust (CLDT), CTI BioPharma (CTIC), Daré Bioscience (DARE) and Dynavax Technologies (DVAX). This page (NASDAQ:SGNT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (SGNT) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.